Marico Limited's Board of Directors, at its meeting held on May 5, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board also recommended a final equity dividend of Rs. 4.00 per equity share of Re. 1 each for FY25-26, subject to shareholder approval at the ensuing 38th Annual General Meeting. The statutory auditors, B S R & Co. LLP, issued their audit reports with an unmodified opinion on both standalone and consolidated financial results.

Key Board Decisions

Alongside the financial results, the Board approved several significant resolutions at its meeting, which commenced at 12:30 p.m. and concluded at 1:45 p.m. on May 5, 2026.

Consolidated Financial Performance

Marico's consolidated financials reflect strong year-on-year growth across key metrics for the year ended March 31, 2026. Revenue from operations grew to Rs. 13,611 crore from Rs. 10,831 crore in the prior year. Net profit for the year stood at Rs. 1,813 crore compared to Rs. 1,658 crore previously. The following table summarises the consolidated income statement highlights:

Net profit attributable to owners for FY26 stood at Rs. 1,762 crore versus Rs. 1,629 crore in FY25, while the share attributable to non-controlling interests was Rs. 51 crore compared to Rs. 29 crore in the prior year.

Consolidated Segment Performance

Marico operates across two reportable segments — India and International. The India segment remained the dominant revenue contributor, while the International segment also delivered meaningful growth.

Standalone Financial Performance

On a standalone basis, Marico reported revenue from operations of Rs. 9,402 crore for FY26 versus Rs. 7,680 crore in FY25. Net profit for the standalone entity rose to Rs. 1,941 crore from Rs. 1,519 crore in the prior year. The standalone results for FY25 have been restated to account for the integration of Apcos Naturals Private Limited (Just Herbs) as a common control business acquisition.

Consolidated Balance Sheet Highlights

Marico's consolidated total assets grew to Rs. 10,075 crore as at March 31, 2026, from Rs. 8,332 crore as at March 31, 2025. Total equity stood at Rs. 4,494 crore versus Rs. 4,266 crore in the prior year. Cash and cash equivalents at the end of FY26 were Rs. 404 crore, up from Rs. 321 crore at the end of FY25.

Consolidated Cash Flow Summary

On a consolidated basis, Marico generated net cash from operating activities of Rs. 2,084 crore for FY26, compared to Rs. 1,363 crore in FY25. Net cash utilised in investing activities stood at Rs. 722 crore, while net cash utilised in financing activities was Rs. 1,279 crore. The net increase in cash and cash equivalents for FY26 was Rs. 83 crore, with closing cash and cash equivalents at Rs. 404 crore.

Key Corporate Developments

Several strategic transactions were completed during FY26 that have shaped the Group's current structure. During the quarter ended June 30, 2025, Marico acquired an additional 8.8% equity stake in Satiya Nutraceuticals Private Limited (Plix) on a fully diluted basis, taking its total stake to 60%. HW Wellness Solutions Private Limited (True Elements) was made a wholly owned subsidiary effective October 17, 2025, following the acquisition of the balance 46.02% equity capital. The business undertaking of Apcos Naturals Private Limited (Just Herbs) was vested in the Company on a going concern basis effective October 1, 2025, pursuant to voluntary liquidation. During the quarter ended March 31, 2026, the Company acquired a 93.27% equity stake in Zea Maize Private Limited (4700BC) effective January 29, 2026, subsequently increasing its stake to 94.02%. Additionally, a 60% equity stake in Cosmix Wellness Private Limited (Cosmix) was acquired effective February 5, 2026.

Company Background and Market Position

During FY25-26, Marico recorded a turnover of ₹136.1 billion (USD 1.5 billion) through its products sold in India and chosen markets in Asia and Africa. The company's domestic portfolio includes brands such as Parachute, Saffola, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Pure Sense, Coco Soul, Revive, Set Wet, Livon, Beardo, Just Herbs, True Elements, Plix, Cosmix and 4700BC, touching the lives of 1 out of every 3 Indians. The overseas consumer products portfolio contributes approximately 24% of the Group's revenue, with international brands including Parachute, Parachute Advansed, HairCode, Fiancée, Herbsindia, Purité de Provence, Ôliv, LASHE Superfood, Candid, Caivil, Hercules, Black Chic, Code 10, Ingwe, X-Men, Thuan Phat and Isoplus.

Marico Limited has announced an investor and analyst conference call scheduled for Tuesday, May 5, 2026, at 5:30 PM IST. The call will follow the company's Board of Directors meeting on the same day, where financial results for the quarter and year ended March 31, 2026, will be approved. Management will provide commentary on the financial performance and operational highlights during the session.

Conference Call Details

The earnings call will be led by senior leadership including Mr. Saugata Gupta – Managing Director & CEO, and Mr. Pawan Agrawal – Group CFO & CEO - International Business. Mr. Harsh Rungta, Head – Investor Relations, will serve as the call leader. Participants can join via multiple dial-in numbers or access the live webcast.

Access and Registration

Participants are advised to dial in at least 5-10 minutes before the scheduled time to ensure timely connection. To avoid waiting queues, investors can register through the Diamond pass link to receive a passcode for direct access. The audio recording and transcript of the conference call will be subsequently published on the company's website at marico.com/india/investors#quarterly.

Company Overview

Marico is one of India's leading consumer products companies operating in global beauty and wellness categories. During FY24-25, the company recorded a turnover of ₹ 108.3 billion (USD 1.3 billion) through products sold in India and selected markets in Asia and Africa. The company's portfolio includes brands such as Parachute, Saffola, Hair & Care, Livon, Beardo, and True Elements. The overseas consumer products business contributes approximately 25% of the Group's revenue.

Investor Contact

For further information or clarification regarding the conference call, investors may contact Mr. Harsh Rungta, Head – Investor Relations at Marico Limited, via telephone at +91-22-66480200 or email at harsh.rungta@marico.com .